Tolerability and efficacy of the monoaminergic stabilizer (−)-OSU6162 (PNU-96391A) in Huntington’s disease: a double-blind cross-over study

Publisher： Cambridge University Press

E-ISSN： 1601-5215|26|5|298-306

ISSN： 0924-2708

Source： Acta Neuropsychiatrica, Vol.26, Iss.5, 2014-06, pp. : 298-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Placebo-controlled cross-over study of the monoaminergic stabiliser (−)-OSU6162 in mental fatigue following stroke or traumatic brain injury

By  

Acta Neuropsychiatrica, Vol. 24, Iss. 5, 2012-10 ,pp. : 266-274

Cambridge University Press

Access to resources Recommend Favorite

Feasibility and Efficacy of Brief Computerized Training to Improve Emotion Recognition in Premanifest and Early-Symptomatic Huntington’s Disease

By  

Journal of the International Neuropsychological Society, Vol. 23, Iss. 4, 2017-03 ,pp. : 314-321

Cambridge University Press

Access to resources Recommend Favorite

Atypical social cognitive processing in premotor Huntington’s disease: a single case study

By  

Irish Journal of Psychological Medicine, Vol. 34, Iss. 1, 2015-10 ,pp. : 53-58

Cambridge University Press

Access to resources Recommend Favorite

Psychodynamic Theory and Counseling in Predictive Testing for Huntington’s Disease

By Tassicker Roslyn  

Journal of Genetic Counseling, Vol. 14, Iss. 2, 2005-04 ,pp. : 99-107

Springer Publishing Company

Access to resources Recommend Favorite

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

By  

International Psychogeriatrics, Vol. 23, Iss. 9, 2011-11 ,pp. : 1515-1519

Cambridge University Press

Access to resources Recommend Favorite